866-997-4948(US-Canada Toll Free)

China Inflammatory Bowel Disease Drugs Market Research Report 2017

Published By :

QYResearch

Published Date : Mar 2017

Category :

Pharmaceutical

No. of Pages : 105 Pages

Notes:
Sales, means the sales volume of Inflammatory Bowel Disease Drugs
Revenue, means the sales value of Inflammatory Bowel Disease Drugs

This report studies Inflammatory Bowel Disease Drugs in China market, focuses on the top players in China market, with capacity, production, price, revenue and market share for each manufacturer, covering
Abbvie
Biogen Idec
Janssen Pharmaceuticals
Merck
Novartis
Shire
UCB
Pfizer
Amgen
Akebia Therapeutics
Boehringer Ingelheim
Celltrion
ChemoCentryx
Ferring Pharmaceuticals
Galapagos
Genentech
Mitsubishi Tanabe
Novo Nordisk
Salix Pharmaceuticals

Market Segment by Regions (provinces), covering
South China
East China
Southwest China
Northeast China
North China
Central China
Northwest China
Split by product Type, with production, revenue, price, market share and growth rate of each type, can be divided into
Oral
Parenteral
Split by Application, this report focuses on consumption, market share and growth rate of Inflammatory Bowel Disease Drugs in each application, can be divided into
Hospital
Clinic

Table of Contents

China Inflammatory Bowel Disease Drugs Market Research Report 2017
1 Inflammatory Bowel Disease Drugs Market Overview
1.1 Product Overview and Scope of Inflammatory Bowel Disease Drugs
1.2 Inflammatory Bowel Disease Drugs Segment by Type
1.2.1 China Production Market Share of Inflammatory Bowel Disease Drugs Type in 2015
1.2.2 Oral
1.2.3 Parenteral
1.3 Applications of Inflammatory Bowel Disease Drugs
1.3.1 Inflammatory Bowel Disease Drugs Consumption Market Share by Application in 2015
1.3.2 Hospital
1.3.3 Clinic
1.4 China Market Size (Value) of Inflammatory Bowel Disease Drugs (2012-2022)
1.5 China Inflammatory Bowel Disease Drugs Status and Outlook
1.6 Government Policies

2 China Inflammatory Bowel Disease Drugs Market Competition by Manufacturers
2.1 China Inflammatory Bowel Disease Drugs Capacity, Production and Share by Manufacturers (2015 and 2016)
2.2 China Inflammatory Bowel Disease Drugs Revenue and Share by Manufacturers (2015 and 2016)
2.3 China Inflammatory Bowel Disease Drugs Average Price by Manufacturers (2015 and 2016)
2.4 Manufacturers Inflammatory Bowel Disease Drugs Manufacturing Base Distribution, Sales Area, Product Type
2.5 Inflammatory Bowel Disease Drugs Market Competitive Situation and Trends
2.5.1 Inflammatory Bowel Disease Drugs Market Concentration Rate
2.5.2 Inflammatory Bowel Disease Drugs Market Share of Top 3 and Top 5 Manufacturers

3 China Inflammatory Bowel Disease Drugs Manufacturers Profiles/Analysis
3.1 Abbvie
3.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
3.1.2 Inflammatory Bowel Disease Drugs Product Type, Application and Specification
3.1.2.1 Product A
3.1.2.2 Product B
3.1.3 Abbvie Inflammatory Bowel Disease Drugs Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
3.1.4 Main Business/Business Overview
3.2 Biogen Idec
3.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
3.2.2 Inflammatory Bowel Disease Drugs Product Type, Application and Specification
3.2.2.1 Product A
3.2.2.2 Product B
3.2.3 Biogen Idec Inflammatory Bowel Disease Drugs Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
3.2.4 Main Business/Business Overview
3.3 Janssen Pharmaceuticals
3.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
3.3.2 Inflammatory Bowel Disease Drugs Product Type, Application and Specification
3.3.2.1 Product A
3.3.2.2 Product B
3.3.3 Janssen Pharmaceuticals Inflammatory Bowel Disease Drugs Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
3.3.4 Main Business/Business Overview
3.4 Merck
3.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
3.4.2 Inflammatory Bowel Disease Drugs Product Type, Application and Specification
3.4.2.1 Product A
3.4.2.2 Product B
3.4.3 Merck Inflammatory Bowel Disease Drugs Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
3.4.4 Main Business/Business Overview
3.5 Novartis
3.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
3.5.2 Inflammatory Bowel Disease Drugs Product Type, Application and Specification
3.5.2.1 Product A
3.5.2.2 Product B
3.5.3 Novartis Inflammatory Bowel Disease Drugs Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
3.5.4 Main Business/Business Overview
3.6 Shire
3.6.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
3.6.2 Inflammatory Bowel Disease Drugs Product Type, Application and Specification
3.6.2.1 Product A
3.6.2.2 Product B
3.6.3 Shire Inflammatory Bowel Disease Drugs Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
3.6.4 Main Business/Business Overview
3.7 UCB
3.7.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
3.7.2 Inflammatory Bowel Disease Drugs Product Type, Application and Specification
3.7.2.1 Product A
3.7.2.2 Product B
3.7.3 UCB Inflammatory Bowel Disease Drugs Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
3.7.4 Main Business/Business Overview
3.8 Pfizer
3.8.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
3.8.2 Inflammatory Bowel Disease Drugs Product Type, Application and Specification
3.8.2.1 Product A
3.8.2.2 Product B
3.8.3 Pfizer Inflammatory Bowel Disease Drugs Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
3.8.4 Main Business/Business Overview
3.9 Amgen
3.9.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
3.9.2 Inflammatory Bowel Disease Drugs Product Type, Application and Specification
3.9.2.1 Product A
3.9.2.2 Product B
3.9.3 Amgen Inflammatory Bowel Disease Drugs Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
3.9.4 Main Business/Business Overview
3.10 Akebia Therapeutics
3.10.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
3.10.2 Inflammatory Bowel Disease Drugs Product Type, Application and Specification
3.10.2.1 Product A
3.10.2.2 Product B
3.10.3 Akebia Therapeutics Inflammatory Bowel Disease Drugs Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
3.10.4 Main Business/Business Overview
3.11 Boehringer Ingelheim
3.12 Celltrion
3.13 ChemoCentryx
3.14 Ferring Pharmaceuticals
3.15 Galapagos
3.16 Genentech
3.17 Mitsubishi Tanabe
3.18 Novo Nordisk
3.19 Salix Pharmaceuticals

4 China Inflammatory Bowel Disease Drugs Capacity, Production, Revenue, Consumption, Export and Import (2012-2017)
4.1 China Inflammatory Bowel Disease Drugs Capacity, Production and Growth (2012-2017)
4.2 China Inflammatory Bowel Disease Drugs Revenue and Growth (2012-2017)
4.3 China Inflammatory Bowel Disease Drugs Production, Consumption, Export and Import (2012-2017)

5 China Inflammatory Bowel Disease Drugs Production, Revenue (Value), Price Trend by Type
5.1 China Inflammatory Bowel Disease Drugs Production and Market Share by Type (2012-2017)
5.2 China Inflammatory Bowel Disease Drugs Revenue and Market Share by Type (2012-2017)
5.3 China Inflammatory Bowel Disease Drugs Price by Type (2012-2017)
5.4 China Inflammatory Bowel Disease Drugs Production Growth by Type (2012-2017)

6 China Inflammatory Bowel Disease Drugs Market Analysis by Application
6.1 China Inflammatory Bowel Disease Drugs Consumption and Market Share by Application (2012-2017)
6.2 China Inflammatory Bowel Disease Drugs Consumption Growth Rate by Application (2012-2017)
6.3 Market Drivers and Opportunities
6.3.1 Potential Application
6.3.2 Emerging Markets/Countries

7 ChinaInflammatory Bowel Disease Drugs Market Analysis by Regions (Provinces)
7.1 China Inflammatory Bowel Disease Drugs Production, Production Value and Price by Regions (Provinces)(2012-2017)
7.1.1 China Inflammatory Bowel Disease Drugs Production and Market Share by Regions (Provinces)(2012-2017)
7.1.2 China Inflammatory Bowel Disease Drugs Production Value and Market Share by Regions (Provinces)(2012-2017)
7.1.3 China Inflammatory Bowel Disease Drugs Sales Price by Regions (Provinces)(2012-2017)
7.2 China Inflammatory Bowel Disease Drugs Consumption by Regions (Provinces)(2012-2017)
7.3 China Inflammatory Bowel Disease Drugs Production, Consumption, Export and Import (2012-2017)

8 Inflammatory Bowel Disease Drugs Manufacturing Cost Analysis
8.1 Inflammatory Bowel Disease Drugs Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Price Trend of Key Raw Materials
8.1.3 Key Suppliers of Raw Materials
8.1.4 Market Concentration Rate of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.2.1 Raw Materials
8.2.2 Labor Cost
8.2.3 Manufacturing Expenses
8.3 Manufacturing Process Analysis of Inflammatory Bowel Disease Drugs

9 Industrial Chain, Sourcing Strategy and Downstream Buyers
9.1 Inflammatory Bowel Disease Drugs Industrial Chain Analysis
9.2 Upstream Raw Materials Sourcing
9.3 Raw Materials Sources of Inflammatory Bowel Disease Drugs Major Manufacturers in 2015
9.4 Downstream Buyers

10 Marketing Strategy Analysis, Distributors/Traders
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List

11 Market Effect Factors Analysis
11.1 Technology Progress/Risk
11.1.1 Substitutes Threat
11.1.2 Technology Progress in Related Industry
11.2 Consumer Needs/Customer Preference Change
11.3 Economic/Political Environmental Change

12 China Inflammatory Bowel Disease Drugs Market Forecast (2017-2022)
12.1 China Inflammatory Bowel Disease Drugs Capacity, Production, Revenue Forecast (2017-2022)
12.2 China Inflammatory Bowel Disease Drugs Production, Import, Export and Consumption Forecast (2017-2022)
12.3 China Inflammatory Bowel Disease Drugs Production Forecast by Type (2017-2022)
12.4 China Inflammatory Bowel Disease Drugs Consumption Forecast by Application (2017-2022)
12.5 China Inflammatory Bowel Disease Drugs Production, Consumption, Import and Export Forecast by Regions (Provinces)(2017-2022)
12.5.1 China Inflammatory Bowel Disease Drugs Production Forecast by Regions (Provinces)(2017-2022)
12.5.2 China Inflammatory Bowel Disease Drugs Consumption Forecast by Regions (Provinces)(2017-2022)
12.5.3 China Inflammatory Bowel Disease Drugs Production, Consumption, Import and Export Forecast by Regions (Provinces)(2017-2022)
12.6 Inflammatory Bowel Disease Drugs Price Forecast (2017-2022)

13 Research Findings and Conclusion

14 Appendix
Methodology
Analyst Introduction
Data Source


List of Table

List of Tables and Figures

Figure Picture of Inflammatory Bowel Disease Drugs
Figure China Production Market Share of Inflammatory Bowel Disease Drugs by Type in 2015
Figure Product Picture of Oral
Table Major Manufacturers of Oral
Figure Product Picture of Parenteral
Table Major Manufacturers of Parenteral
Table Inflammatory Bowel Disease Drugs Consumption Market Share by Application in 2015
Figure Hospital Examples
Figure Clinic Examples
Figure China Inflammatory Bowel Disease Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Table China Inflammatory Bowel Disease Drugs Capacity of Key Manufacturers (2015 and 2016)
Table China Inflammatory Bowel Disease Drugs Capacity Market Share of Key Manufacturers (2015 and 2016)
Figure China Inflammatory Bowel Disease Drugs Capacity of Key Manufacturers in 2015
Figure China Inflammatory Bowel Disease Drugs Capacity of Key Manufacturers in 2016
Table China Inflammatory Bowel Disease Drugs Production of Key Manufacturers (2015 and 2016)
Table China Inflammatory Bowel Disease Drugs Production Share by Manufacturers (2015 and 2016)
Figure 2015 Inflammatory Bowel Disease Drugs Production Share by Manufacturers
Figure 2016 Inflammatory Bowel Disease Drugs Production Share by Manufacturers
Table China Inflammatory Bowel Disease Drugs Revenue (Million USD) by Manufacturers (2015 and 2016)
Table China Inflammatory Bowel Disease Drugs Revenue Share by Manufacturers (2015 and 2016)
Table 2015 China Inflammatory Bowel Disease Drugs Revenue Share by Manufacturers
Table 2016 China Inflammatory Bowel Disease Drugs Revenue Share by Manufacturers
Table China Market Inflammatory Bowel Disease Drugs Average Price of Key Manufacturers (2015 and 2016)
Figure China Market Inflammatory Bowel Disease Drugs Average Price of Key Manufacturers in 2015
Table Manufacturers Inflammatory Bowel Disease Drugs Manufacturing Base Distribution and Sales Area
Table Manufacturers Inflammatory Bowel Disease Drugs Product Type
Figure Inflammatory Bowel Disease Drugs Market Share of Top 3 Manufacturers
Figure Inflammatory Bowel Disease Drugs Market Share of Top 5 Manufacturers
Table Abbvie Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Abbvie Inflammatory Bowel Disease Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
Figure Abbvie Inflammatory Bowel Disease Drugs Market Share (2012-2017)
Table Biogen Idec Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Biogen Idec Inflammatory Bowel Disease Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
Figure Biogen Idec Inflammatory Bowel Disease Drugs Market Share (2012-2017)
Table Janssen Pharmaceuticals Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Janssen Pharmaceuticals Inflammatory Bowel Disease Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
Figure Janssen Pharmaceuticals Inflammatory Bowel Disease Drugs Market Share (2012-2017)
Table Merck Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Merck Inflammatory Bowel Disease Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
Figure Merck Inflammatory Bowel Disease Drugs Market Share (2012-2017)
Table Novartis Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Novartis Inflammatory Bowel Disease Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
Figure Novartis Inflammatory Bowel Disease Drugs Market Share (2012-2017)
Table Shire Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Shire Inflammatory Bowel Disease Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
Figure Shire Inflammatory Bowel Disease Drugs Market Share (2012-2017)
Table UCB Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table UCB Inflammatory Bowel Disease Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
Figure UCB Inflammatory Bowel Disease Drugs Market Share (2012-2017)
Table Pfizer Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Pfizer Inflammatory Bowel Disease Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
Figure Pfizer Inflammatory Bowel Disease Drugs Market Share (2012-2017)
Table Amgen Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Amgen Inflammatory Bowel Disease Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
Figure Amgen Inflammatory Bowel Disease Drugs Market Share (2012-2017)
Table Akebia Therapeutics Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Akebia Therapeutics Inflammatory Bowel Disease Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
Figure Akebia Therapeutics Inflammatory Bowel Disease Drugs Market Share (2012-2017)
Table Boehringer Ingelheim Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Celltrion Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table ChemoCentryx Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Ferring Pharmaceuticals Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Galapagos Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Genentech Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Mitsubishi Tanabe Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Novo Nordisk Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Salix Pharmaceuticals Basic Information, Manufacturing Base, Sales Area and Its Competitors
Figure China Inflammatory Bowel Disease Drugs Capacity, Production and Growth (2012-2017)
Figure China Inflammatory Bowel Disease Drugs Revenue (Million USD) and Growth (2012-2017)
Table China Inflammatory Bowel Disease Drugs Production, Consumption, Export and Import (2012-2017)
Table China Inflammatory Bowel Disease Drugs Production by Type (2012-2017)
Table China Inflammatory Bowel Disease Drugs Production Share by Type (2012-2017)
Figure Production Market Share of Inflammatory Bowel Disease Drugs by Type (2012-2017)
Figure 2015 Production Market Share of Inflammatory Bowel Disease Drugs by Type
Table China Inflammatory Bowel Disease Drugs Revenue by Type (2012-2017)
Table China Inflammatory Bowel Disease Drugs Revenue Share by Type (2012-2017)
Figure Production Revenue Share of Inflammatory Bowel Disease Drugs by Type (2012-2017)
Figure 2015 Revenue Market Share of Inflammatory Bowel Disease Drugs by Type
Table China Inflammatory Bowel Disease Drugs Price by Type (2012-2017)
Figure China Inflammatory Bowel Disease Drugs Production Growth by Type (2012-2017)
Table China Inflammatory Bowel Disease Drugs Consumption by Application (2012-2017)
Table China Inflammatory Bowel Disease Drugs Consumption Market Share by Application (2012-2017)
Figure China Inflammatory Bowel Disease Drugs Consumption Market Share by Application in 2015
Table China Inflammatory Bowel Disease Drugs Consumption Growth Rate by Application (2012-2017)
Figure China Inflammatory Bowel Disease Drugs Consumption Growth Rate by Application (2012-2017)
Table China Inflammatory Bowel Disease Drugs Production by Regions (Provinces)(2012-2017)
Table China Inflammatory Bowel Disease Drugs Production Market Share by Regions (Provinces)(2012-2017)
Table China Inflammatory Bowel Disease Drugs Production Value by Regions (Provinces)(2012-2017)
Table China Inflammatory Bowel Disease Drugs Production Value Market Share by Regions (Provinces)(2012-2017)
Table China Inflammatory Bowel Disease Drugs Sales Price by Regions (Provinces)(2012-2017)
Table China Inflammatory Bowel Disease Drugs Consumption by Regions (Provinces)(2012-2017)
Table China Inflammatory Bowel Disease Drugs Consumption Market Share by Regions (Provinces)(2012-2017)
Table China Inflammatory Bowel Disease Drugs Production, Consumption, Export and Import (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Inflammatory Bowel Disease Drugs
Figure Manufacturing Process Analysis of Inflammatory Bowel Disease Drugs
Figure Inflammatory Bowel Disease Drugs Industrial Chain Analysis
Table Raw Materials Sources of Inflammatory Bowel Disease Drugs Major Manufacturers in 2015
Table Major Buyers of Inflammatory Bowel Disease Drugs
Table Distributors/Traders List
Figure China Inflammatory Bowel Disease Drugs Capacity, Production and Growth Rate Forecast (2017-2022)
Figure China Inflammatory Bowel Disease Drugs Revenue and Growth Rate Forecast (2017-2022)
Table China Inflammatory Bowel Disease Drugs Production, Import, Export and Consumption Forecast (2017-2022)
Table China Inflammatory Bowel Disease Drugs Production Forecast by Type (2017-2022)
Table China Inflammatory Bowel Disease Drugs Consumption Forecast by Application (2017-2022)
Table China Inflammatory Bowel Disease Drugs Production Forecast by Regions (Provinces)(2017-2022)
Table China Inflammatory Bowel Disease Drugs Consumption Forecast by Regions (Provinces)(2017-2022)
Table China Inflammatory Bowel Disease Drugs Production, Consumption, Import and Export Forecast by Regions (Provinces)(2017-2022)

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title *
  • Company *
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *